Regenics works with AlphaLyse (Dk, US) in the molecular characterization of marine derived bioactives.

Alphalyse is a CRO and protein analysis lab, which offers unique global impurity analysis and analytical protein characterization services. Through our lab and offices in Denmark and USA, we help customers seeking to analyse protein related impurities, or outsource verification of protein analysis results by mass spectrometry.

 

Contact information:

 

https://www.alphalyse.com/contact/

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.